Caixin
Apr 28, 2022 08:00 AM

Guangdong Vtr Bio-Tech Co.,Ltd. Posted 26.8 Million Yuan Net Loss in First Quarter of 2022

Guangdong Vtr Bio-Tech Co.,Ltd. (广东溢多利生物科技股份有限公司) (300381.SZ) reported a net loss of 26.8 million yuan in the first quarter of 2022, reversing a net profit of 34.9 million yuan for the same period in the previous year.

Meanwhile, the company posted 423.5 million yuan in revenue, up 6.6% year-on-year.

At the end of the reporting period, it had 4.6 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 33.7%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Inside Vanke and China’s Property Reckoning
00:00
00:00/00:00